Home Healthcare Biotechnology mRNA Vaccines and Therapeutics Market

mRNA Vaccines and Therapeutics Market Size, Share & Trends Analysis Report By Applications (COVID-19 mRNA vaccines, Non-COVID-19 mRNA vaccines), By mRNA type (COVID-19, Non-COVID-19) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 08, 2026 | Author: Dhanashri B | Format: | Report Code: SR4180DR | Pages: 150
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. mRNA Vaccines and Therapeutics Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. COVID-19 mRNA vaccines
      1. Commercialized Vaccines
      2. Pipeline Vaccines
    2. Non-COVID-19 mRNA vaccines
      1. Oncology
      2. Infectious Diseases
      3. Other Diseases
  2. mRNA Vaccines and Therapeutics Market, By mRNA type 2022-2034 (USD MILLION/ Units)
    1. COVID-19
      1. Nucleoside-Modified mRNA (modRNA)
      2. Unmodified mRNA
      3. Self-Amplifying mRNA
    2. Non-COVID-19
      1. Nucleoside-Modified mRNA (modRNA)
      2. Unmodified mRNA
      3. Self-Amplifying mRNA)
  3. Regional mRNA Vaccines and Therapeutics Market
    1. North America
      1. North America mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      2. North America mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
      3. U.S. mRNA Vaccines and Therapeutics Market
        1. U.S. mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. U.S. mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      4. Canada mRNA Vaccines and Therapeutics Market
        1. Canada mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Canada mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
    2. Europe
      1. Europe mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      2. Europe mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
      3. U.K. mRNA Vaccines and Therapeutics Market
        1. U.K. mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. U.K. mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      4. Germany mRNA Vaccines and Therapeutics Market
        1. Germany mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Germany mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      5. France mRNA Vaccines and Therapeutics Market
        1. France mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. France mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      6. Spain mRNA Vaccines and Therapeutics Market
        1. Spain mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Spain mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      7. Italy mRNA Vaccines and Therapeutics Market
        1. Italy mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Italy mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      8. Russia mRNA Vaccines and Therapeutics Market
        1. Russia mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Russia mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      9. Nordic mRNA Vaccines and Therapeutics Market
        1. Nordic mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Nordic mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      10. Benelux mRNA Vaccines and Therapeutics Market
        1. Benelux mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Benelux mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      11. Rest of Europe mRNA Vaccines and Therapeutics Market
        1. Rest of Europe mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Rest of Europe mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
    3. APAC
      1. APAC mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      2. APAC mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
      3. China mRNA Vaccines and Therapeutics Market
        1. China mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. China mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      4. Korea mRNA Vaccines and Therapeutics Market
        1. Korea mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Korea mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      5. Japan mRNA Vaccines and Therapeutics Market
        1. Japan mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Japan mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      6. India mRNA Vaccines and Therapeutics Market
        1. India mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. India mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      7. Australia mRNA Vaccines and Therapeutics Market
        1. Australia mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Australia mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      8. Taiwan mRNA Vaccines and Therapeutics Market
        1. Taiwan mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Taiwan mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      9. South East Asia mRNA Vaccines and Therapeutics Market
        1. South East Asia mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. South East Asia mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      10. Rest of Asia-Pacific mRNA Vaccines and Therapeutics Market
        1. Rest of Asia-Pacific mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Rest of Asia-Pacific mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
    4. Middle East and Africa
      1. Middle East and Africa mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      2. Middle East and Africa mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
      3. UAE mRNA Vaccines and Therapeutics Market
        1. UAE mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. UAE mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      4. Turkey mRNA Vaccines and Therapeutics Market
        1. Turkey mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Turkey mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      5. Saudi Arabia mRNA Vaccines and Therapeutics Market
        1. Saudi Arabia mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Saudi Arabia mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      6. South Africa mRNA Vaccines and Therapeutics Market
        1. South Africa mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. South Africa mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      7. Egypt mRNA Vaccines and Therapeutics Market
        1. Egypt mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Egypt mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      8. Nigeria mRNA Vaccines and Therapeutics Market
        1. Nigeria mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Nigeria mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      9. Rest of MEA mRNA Vaccines and Therapeutics Market
        1. Rest of MEA mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Rest of MEA mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
    5. LATAM
      1. LATAM mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. COVID-19 mRNA vaccines
          1. Commercialized Vaccines
          2. Pipeline Vaccines
        2. Non-COVID-19 mRNA vaccines
          1. Oncology
          2. Infectious Diseases
          3. Other Diseases
      2. LATAM mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
        1. COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA
        2. Non-COVID-19
          1. Nucleoside-Modified mRNA (modRNA)
          2. Unmodified mRNA
          3. Self-Amplifying mRNA)
      3. Brazil mRNA Vaccines and Therapeutics Market
        1. Brazil mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Brazil mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      4. Mexico mRNA Vaccines and Therapeutics Market
        1. Mexico mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Mexico mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      5. Argentina mRNA Vaccines and Therapeutics Market
        1. Argentina mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Argentina mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      6. Chile mRNA Vaccines and Therapeutics Market
        1. Chile mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Chile mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      7. Colombia mRNA Vaccines and Therapeutics Market
        1. Colombia mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Colombia mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
      8. Rest of LATAM mRNA Vaccines and Therapeutics Market
        1. Rest of LATAM mRNA Vaccines and Therapeutics Market By Applications 2022-2034 (USD MILLION/ Units)
          1. COVID-19 mRNA vaccines
            1. Commercialized Vaccines
            2. Pipeline Vaccines
          2. Non-COVID-19 mRNA vaccines
            1. Oncology
            2. Infectious Diseases
            3. Other Diseases
        2. Rest of LATAM mRNA Vaccines and Therapeutics Market By mRNA type 2022-2034 (USD MILLION/ Units)
          1. COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA
          2. Non-COVID-19
            1. Nucleoside-Modified mRNA (modRNA)
            2. Unmodified mRNA
            3. Self-Amplifying mRNA)
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.